Zobrazeno 1 - 10
of 1 209
pro vyhledávání: '"Yair, Lotan"'
Autor:
Francesco Gatto, Sinisa Bratulic, Francesca Maccari, Fabio Galeotti, Nicola Volpi, Jens Nielsen, Yair Lotan, Henrik Kjölhede
Publikováno v:
European Urology Open Science, Vol 68, Iss , Pp 40-47 (2024)
Background and objective: Screening for bladder cancer (BCa) could reduce mortality via early detection of early-stage high-grade (Ta/T1 N0 M0 grade 2–3) disease. Noninvasive biomarkers could aid in screening, but current markers lack the specifici
Externí odkaz:
https://doaj.org/article/ea6532441b704085861bdd4e804a3f8e
Autor:
Tessa Ladner, Anna J. Black, Homayoun Zargar, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeff M. Holzbeierlein, Michael S. Cookson, Niels-Erik Jacobsen, Adrian S. Fairey, Colin P. N. Dinney, Maria C. Mir, Laura-Maria Krabbe, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, Evanguelos Xylinas, Andrew J. Stephenson, Jay B. Shah, Siamak Daneshmand, Kamran Zargar-Shoshtari, Philippe E. Spiess, Laura S. Mertens, Bas W. G. van Rhijn, Petros Grivas, Wassim Kassouf, Marc A. Dall’Era, Srikala S. Sridhar, Jonathan S. McGrath, Jonathan Aning, Shahrokh F. Shariat, Trinity J. Bivalacqua, Scott A. North, Daniel A. Barocas, Yair Lotan, Peter C. Black
Publikováno v:
Société Internationale d’Urologie Journal, Vol 5, Iss 3, Pp 202-213 (2024)
Objectives: Perioperative blood transfusion (PBT) has been associated with worse survival after radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC). Here, we evaluated the association between PBT and survival after RC that
Externí odkaz:
https://doaj.org/article/014c07b617934d568005c539c0294ffb
Autor:
Florian R. Schroeck, Robert Grubb, Todd A. MacKenzie, A. Aziz Ould Ismail, Laura Jensen, Gregory J. Tsongalis, Yair Lotan
Publikováno v:
European Urology Open Science, Vol 63, Iss , Pp 19-30 (2024)
“Replace Cysto” is a multisite randomized phase 2 trial including 240 participants with low-grade intermediate-risk non–muscle-invasive bladder cancer, in which participants will be randomized 1:1:1 to one of two urine marker–based approaches
Externí odkaz:
https://doaj.org/article/2ec54448cdc54f309fb00e4a5ce6c83d
Autor:
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey Elizabeth Dobrolecki, David J. H. Shih, Zhongcheng Shi, Jun Xu, Shixia Huang, Matthew J. Ellis, Andrea B. Apolo, Leomar Y. Ballester, Jianjun Gao, Donna E. Hansel, Yair Lotan, H. Courtney Hodges, Seth P. Lerner, Chad J. Creighton, Arun Sreekumar, W. Jim Zheng, Pavlos Msaouel, Shyam M. Kavuri, Nagireddy Putluri
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract SMARCB1 loss has long been observed in many solid tumors. However, there is a need to elucidate targetable pathways driving growth and metastasis in SMARCB1-deficient tumors. Here, we demonstrate that SMARCB1 deficiency, defined as genomic S
Externí odkaz:
https://doaj.org/article/92dacc4a9b18472087b40b7343faadf4
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background To estimate the economic impact of preventing urinary tract infections (UTI) by increasing water intake among women with recurrent UTI and low fluid intake across seven countries: France, United Kingdom, Spain, United States of Am
Externí odkaz:
https://doaj.org/article/5f7afc6f7c294ce7a27d463a562e1407
Autor:
John L. Gore, Erika M. Wolff, Bryan A. Comstock, Kristin M. Follmer, Michael G. Nash, Anirban Basu, Stephanie Chisolm, Douglas B. MacLean, Jenney R. Lee, Yair Lotan, Sima P. Porten, Gary D. Steinberg, Sam S. Chang, Scott M. Gilbert, Larry G. Kessler, Angela B. Smith, CISTO Collaborative
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Bladder cancer poses a significant public health burden, with high recurrence and progression rates in patients with non-muscle-invasive bladder cancer (NMIBC). Current treatment options include bladder-sparing therapies (BST) and
Externí odkaz:
https://doaj.org/article/3af6c3a91f5d4425a09260ced928bdc7
Autor:
Markus von Deimling, Laura S. Mertens, Bas W.G. van Rhijn, Yair Lotan, Philippe E. Spiess, Siamak Daneshmand, Peter C. Black, Maximilian Pallauf, David D'Andrea, Marco Moschini, Francesco Soria, Francesco Del Giudice, Luca Afferi, Ekaterina Laukhtina, Takafumi Yanagisawa, Tatsushi Kawada, Jeremy Y.-C. Teoh, Mohammad Abufaraj, Guillaume Ploussard, Mathieu Roumiguié, Pierre I. Karakiewicz, Marko Babjuk, Paolo Gontero, Evanguelos Xylinas, Michael Rink, Shahrokh F. Shariat, Benjamin Pradere
Publikováno v:
European Urology Open Science, Vol 51, Iss , Pp 39-46 (2023)
Background: There are currently no guideline recommendations regarding the treatment of cisplatin-ineligible, clinically lymph node–positive (cN+) bladder cancer (BCa). Objective: To investigate the oncological efficacy of gemcitabine/carboplatin i
Externí odkaz:
https://doaj.org/article/ca1ab60ba464424d84a6c7187bdbb8f7
Autor:
Kamala Vanarsa, Jessica Castillo, Long Wang, Kyung Hyun Lee, Claudia Pedroza, Yair Lotan, Chandra Mohan
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract Background Bladder cancer (BC) is among the most common cancers diagnosed in men in the USA. The current gold standards for the diagnosis of BC are invasive or lack the sensitivity to correctly identify the disease. Methods An aptamer-based
Externí odkaz:
https://doaj.org/article/2637d1383951463cb0f1fec153416f10
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/e840139ff2e44a4db19000df112efa6a
Autor:
Maximilian Pallauf, Frederik König, David D’Andrea, Ekaterina Laukhtina, Hadi Mostafaei, Reza Sari Motlagh, Fahad Quhal, Abdulmajeed Aydh, Takafumi Yanagisawa, Tatsushi Kawada, Pawel Rajwa, Lukas Lusuardi, Francesco Soria, Pierre I. Karakiewicz, Morgan Rouprêt, Michael Rink, Yair Lotan, Vitaly Margulis, Nirmish Singla, Evanguelos Xylinas, Shahrokh F. Shariat, Benjamin Pradere
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundCurrent guidelines recommend assessing the prognosis in high-risk upper tract urothelial carcinoma patients (UTUC) after surgery. However, no specific method is endorsed. Among the various prognostic models, nomograms represent an easy and
Externí odkaz:
https://doaj.org/article/a7e1a241386944bb8927910d43a20c1d